Safety of recombinant activated factor VII for bleeding use post Heart Mate III, left ventricular assist device implantation.
- DOI
- 10.1016/j.jhlto.2026.100594
- Published
- 2026 Aug
- Container
- JHLT open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jhlto.2026.100594,
title = {Safety of recombinant activated factor VII for bleeding use post Heart Mate III, left ventricular assist device implantation.},
author = {Al-Kaf FA and AlRifaie R and Songor H and Alreshidan M},
year = {2026},
journal = {JHLT open},
doi = {10.1016/j.jhlto.2026.100594},
url = {https://doi.org/10.1016/j.jhlto.2026.100594}
}RIS
TY - JOUR TI - Safety of recombinant activated factor VII for bleeding use post Heart Mate III, left ventricular assist device implantation. AU - Al-Kaf FA AU - AlRifaie R AU - Songor H AU - Alreshidan M PY - 2026 JO - JHLT open DO - 10.1016/j.jhlto.2026.100594 UR - https://doi.org/10.1016/j.jhlto.2026.100594 ER -
APA
FA, A., R, A., H, S., & M, A. (2026). Safety of recombinant activated factor VII for bleeding use post Heart Mate III, left ventricular assist device implantation.. JHLT open. https://doi.org/10.1016/j.jhlto.2026.100594
Source records
- pubmed · retrieved 2026-09-26T01:05:09.611Z